| pubmed-article:1335664 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1335664 | lifeskim:mentions | umls-concept:C0019159 | lld:lifeskim |
| pubmed-article:1335664 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:1335664 | pubmed:dateCreated | 1993-2-1 | lld:pubmed |
| pubmed-article:1335664 | pubmed:abstractText | A review of the literature shows that 30-35 million travellers from industrialized nations annually visit a developing country where their incidence rate of symptomatic hepatitis A is 3 to 6 per 1000 per month of stay if they remain unprotected. The risk is 20 per 1000 for persons eating and drinking under poor hygienic conditions. Thus hepatitis A is now the most frequent vaccine-preventable disease in such travellers. Antibodies to hepatitis A virus are rarely found in potential travellers in many industrialized countries, except in those born before 1944, in those with a history of jaundice, or in those with a stay > 1 year in a developing country. | lld:pubmed |
| pubmed-article:1335664 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1335664 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1335664 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1335664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1335664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1335664 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1335664 | pubmed:issn | 0264-410X | lld:pubmed |
| pubmed-article:1335664 | pubmed:author | pubmed-author:SteffesMM | lld:pubmed |
| pubmed-article:1335664 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1335664 | pubmed:volume | 10 Suppl 1 | lld:pubmed |
| pubmed-article:1335664 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1335664 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1335664 | pubmed:pagination | S69-72 | lld:pubmed |
| pubmed-article:1335664 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:meshHeading | pubmed-meshheading:1335664-... | lld:pubmed |
| pubmed-article:1335664 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1335664 | pubmed:articleTitle | Risk of hepatitis A in travellers. | lld:pubmed |
| pubmed-article:1335664 | pubmed:affiliation | Division of Epidemiology and Prevention of Communicable Diseases, Institute of Social and Preventive Medicine of the University, Zurich, Switzerland. | lld:pubmed |
| pubmed-article:1335664 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1335664 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1335664 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1335664 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1335664 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1335664 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1335664 | lld:pubmed |
